Updated Jul 16, 2026
McLeod Ian is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Ian Mcleod is an executive associated with Anika Therapeutics, Inc., a company focused on developing and commercializing products for tissue protection, healing, and repair. He has been involved in various roles within the company, contributing to its strategic direction and growth in the biopharmaceutical sector.
| Role | Insider |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-17 | ANIK | Anika Therapeutics, Inc. | F — Tax withholding / forfeiture | 781 | $14.20 | $11K |
| 2026-03-17 | ANIK | Anika Therapeutics, Inc. | M — Option exercise | 2.7K | — | |
| 2026-03-17 | ANIK | Anika Therapeutics, Inc. | F — Tax withholding / forfeiture | 1.4K | $14.20 | $21K |
| 2026-03-17 | ANIK | Anika Therapeutics, Inc. | A — Grant or award | 1.2K | $0.00 | |
| 2026-03-17 | ANIK | Anika Therapeutics, Inc. | M — Option exercise | 3.8K | — | |
| 2026-03-11 | ANIK | Anika Therapeutics, Inc. | F — Tax withholding / forfeiture | 639 | $14.96 | $10K |
| 2026-03-11 | ANIK | Anika Therapeutics, Inc. | M — Option exercise | 2.2K | — |
Ian Mcleod is an executive associated with Anika Therapeutics, Inc., a company focused on developing and commercializing products for tissue protection, healing, and repair. He has been involved in various roles within the company, contributing to its strategic direction and growth in the biopharmaceutical sector.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McLeod Ian profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.